Advertisement
ResearchIn-Press PreviewHepatology Open Access | 10.1172/JCI171691
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Ogino, N. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Leite, M. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Guerra, M. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Kruglov, E. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Asashima, H. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Hafler, D. in: JCI | PubMed | Google Scholar |
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Ito, T. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Pereira, J. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Peiffer, B. in: JCI | PubMed | Google Scholar |
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Sun, Z. in: JCI | PubMed | Google Scholar
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Ehrlich, B. in: JCI | PubMed | Google Scholar |
1Yale Liver Center, Yale University School of Medicine, New Haven, United States of America
2Department of Neurology, Yale University School of Medicine, New Haven, United States of America
3Department of Immunobiology and Yale Stem Cell Center, Yale University School of Medicine, New Haven, United States of America
4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, United States of America
Find articles by Nathanson, M. in: JCI | PubMed | Google Scholar
Published June 25, 2024 - More info
Neutrophil infiltration occurs in a variety of liver diseases, but it is unclear how neutrophils and hepatocytes interact. Neutrophils generally use granule proteases to digest phagocytosed bacteria and foreign substances or neutralize them in neutrophil extracellular traps. In certain pathological states, granule proteases play a destructive role against the host as well. More recently, non-destructive actions of neutrophil granule proteins have been reported, such as modulation of tissue remodeling and metabolism. Here we report a completely different mechanism by which neutrophils act non-destructively, by inserting granules directly into hepatocytes. Specifically, elastase-containing granules were transferred to hepatocytes where elastase selectively degraded intracellular calcium channels to reduce cell proliferation without cytotoxicity. In response, hepatocytes increased expression of serpin E2 and A3, which inhibited elastase activity. Elastase insertion was seen in patient specimens of alcohol-associated hepatitis, and the relationship between elastase-mediated ITPR2 degradation and reduced cell proliferation was confirmed in mouse models. Moreover, neutrophils from patients with alcohol-associated hepatitis were more prone to degranulation and more potent in reducing calcium channel expression than neutrophils from healthy subjects. This non-destructive and reversible action on hepatocytes defines a previously unrecognized role for neutrophils in the transient regulation of epithelial calcium signaling mechanisms.